The long-term use of antibiotics can cause drug resistance. Natural polysaccharides are a novel means of treating bacterial infections, and the development and utilization of litchi pericarp polysaccharide (LPPs) as a bacteriostatic active substance offer a new research direction for the high-value utilization of litchi by-products. This study revealed that LPPs inhibited Staphylococcus aureus more than Escherichia coli, Listeria monocytogenes, and Salmonella typhimurium, with the minimum inhibitory concentrations of 145, 205, 325, and 445 μg/mL, respectively. The inhibitory activity of LPPs was insignificant for Bacillus subtilis at 505 μg/mL. The assessment of antibacterial mechanisms revealed that LPPs influenced the growth, conductivity, protein, and nucleic acid, reducing sugar, respiratory chain dehydrogenase activity, bacterial lipid peroxidation, intracellular adenosine triphosphate, and extracellular alkaline phosphatase levels of S. aureus. Of note, LPPs could modify the cell wall integrity and cell membrane permeability of S. aureus, resulting in the leakage of intracellular large and small molecules, inhibition of cellular respiratory metabolism, and oxidative losses. These processes exhibited an inhibitory effect and made the bacterium nonfunctional, thereby affecting its growth and metabolism or causing cell death. These findings provide support and insights into the potential application of LPPs as a natural antimicrobial agent.
Litchi chinensis Sonn. (litchi) pericarp, a major byproduct of litchi processing, is rich in bioactive polysaccharides; however, the structure-bioactivity relationship has not been well studied. Here, a homogenous polysaccharide LPPs-1 was isolated and purified from litchi pericarp, having a weight-average molecular weight of 38.97 kDa (polydispersity index <1.6) and containing the following 9 monosaccharides: L-rhamnose, D-galacturonic acid, D-galactose, L-arabinose, d-glucose, D-xylose, D-mannose, L-fucose, and D-glucuronic acid in a 3.84: 18.55: 13.77: 28.01: 14.06: 9.42: 10.10: 1.18: 1.06 M ratio. NMR spectroscopy identified a → 4)-α-D-GalpA-(1→, →3,6)-β-D-Galp-(1→, and →5)-α-L Araf-(1 → backbone, in a 22.03: 14.06: 10.74 M ratio. Notably, LPPs-1 reversibly inhibited α-amylase (hybrid) and α-glucosidase (uncompetitive) (IC50s: 0.16 mg/mL and 0.24 mg/mL, respectively). The dual enzyme-inhibitory effect of LPPs-1 suggests its potential as a naturally occurring hypoglycemic agent. Our findings indicate the potential of litchi pericarp polysaccharides as a functional food in the management of diabetes.